Loading resource…

Steven A. Greenberg
Inclusion body myositis (IBM) is a slowly progressive skeletal muscle disease characterized by unique clinical features such as finger flexor and quadriceps weakness, along with pathological features including the presence of infiltrating cytotoxic T cells in muscle. Recent findings suggest that IBM may be an autoimmune T cell-mediated disease, challenging previous notions of its treatment refractoriness. Advances in biomarker identification and genetic studies have provided new insights into the disease's pathogenesis and potential therapeutic avenues.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Traumatic Brain Injury
Same clinical topic · Neurology

Classification of the Epilepsies
Same clinical topic · Neurology

Neuroimaging Patterns of Intracranial Infections: Meningitis, Cerebritis, and Their Complications
Same clinical topic · Neurology

An update on management of subarachnoid haemorrhage
Same clinical topic · Neurology

INCLUSION BODY MYOSITIS
Same clinical topic · Neurology

ENCEPHALITIS
Same clinical topic · Neurology

INTRACEREBRAL HAEMORRHAGE
Same clinical topic · Neurology

INCLUSION BODY MYOSITIS
Same clinical topic · Neurology

PREVENTION OF STROKE
Same clinical topic · Neurology